Ola Bratt

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Prostate Cancer

Radical Prostatectomy

Top Venues

Scandinavian journal of urology

BJU international

European journal of preventive cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Ola Bratt
A note on the importance of wording. European journal of preventive cardiology (2023)
Ola Bratt
The Swedish prostate cancer guidelines: response to Axcrona and Löffeler. Scandinavian journal of urology 56 (4) (2022)
Ola Bratt
Has the time come for routine use of PET/CT for guiding treatment of biochemical recurrence after radical prostatectomy? RE: JaniAB, et al. 18 F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet. 2021 May 22;55:1895-1904. Scandinavian journal of urology 55 (5) (2022)
Ola Bratt, Stefan Carlsson, Per Fransson, Jon Kindblom, Johan Stranne, Camilla Thellenberg Karlsson, null null
The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease. Scandinavian journal of urology 56 (4) (2022)
Ola Bratt
Integrating magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography/computed tomography results into prostate cancer treatment decision making. BJU international 129 (1) (2022)
Kenneth A Iczkowski, Mariel Molina, Lars Egevad, David G Bostwick, G J L H Geert van Leenders, Francisco G La Rosa, Theodorus van der Kwast, Daniel M Berney, Andrew J Evans, Thomas M Wheeler, Katia R M Leite, Hemamali Samaratunga, John Srigley, Murali Varma, Toyonori Tsuzuki, Marshall Scott Lucia, Elward David Crawford, Richard G Harris, Philip Stricker, Nathan Lawrentschuk, Henry H Woo, Neil E Fleshner, Neal D Shore, John Yaxley, Ola Bratt, Peter Wiklund, Matthew John Roberts, Liang Cheng, Brett Delahunt
Low-grade prostate cancer should still be labelled cancer. BJU international 130 (6) (2022)
Ola Bratt, Stefan Carlsson, Per Fransson, Camilla Thellenberg Karlsson, Johan Stranne, Jon Kindblom, null null
The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease. Scandinavian journal of urology 56 (4) (2022)
Andreas Forsvall, Jane Fisher, Magnus Wagenius, Christian Broman, Dejan Korkocic, Ola Bratt, Adam Linder
Prostate biopsy quality and patient experience with the novel Forsvall biopsy needle - a randomized controlled non-inferiority trial. Scandinavian journal of urology 55 (3) (2021)
Andreas Forsvall, Jane Fisher, José Francisco Pereira Cardoso, Magnus Wagenius, Jonas Tverring, Bo Nilson, Andreas B Dahlin, Ola Bratt, Adam Linder, Tirthankar Mohanty
Evaluation of the Forsvall biopsy needle in an ex vivo model of transrectal prostate biopsy - a novel needle design with the objective to reduce the risk of post-biopsy infection. Scandinavian journal of urology 55 (3) (2021)
Andreas Forsvall, Hannah Jönsson, Magnus Wagenius, Ola Bratt, Adam Linder
Rate and characteristics of infection after transrectal prostate biopsy: a retrospective observational study. Scandinavian journal of urology 55 (4) (2021)
Ola Bratt, Hans Lilja
Modern prostate cancer diagnostics reduce overdiagnosis - will they open up for population-based screening? Scandinavian journal of urology 55 (6) (2021)
Ola Bratt, Linda Drevin, Karl-Göran Prütz, Stefan Carlsson, Lars Wennberg, Pär Stattin
Prostate cancer in kidney transplant recipients - a nationwide register study. BJU international 125 (5) (2020)
David L Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan-Erik Damber, Ola Bratt, Lars Holmberg, Lars-Olof Wahlund, Pär Stattin, Jan Adolfsson
Androgen deprivation therapy for prostate cancer and risk of dementia. BJU international 124 (1) (2019)
Vincent J Gnanapragasam, Tristan Barrett, Vineetha Thankapannair, David R Thurtle, Jose Rubio-Briones, Jose Domínguez-Escrig, Ola Bratt, Par Statin, Kenneth Muir, Artitaya Lophatananon
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer. BJU international 124 (5) (2019)
Ola Bratt
RE: Preissner F, et al. extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion. The Prostate. 2018;1-7. The Prostate 78 (9) (2018)